Concentrix Bilan de santé
Santé financière contrôle des critères 1/6
Concentrix possède un total de capitaux propres de $2.8B et une dette totale de $4.8B, ce qui porte son ratio d'endettement à 170.4%. Son actif total et son passif total sont $10.7B et de $7.9B. L'EBIT de Concentrix est $572.1M ce qui fait que son ratio de couverture des intérêts 1.6. Elle dispose de liquidités et de placements à court terme de $222.7M.
Informations clés
170.36%
Ratio d'endettement
US$4.75b
Dette
| Ratio de couverture des intérêts | 1.6x |
| Argent liquide | US$222.70m |
| Fonds propres | US$2.79b |
| Total du passif | US$7.89b |
| Total des actifs | US$10.67b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
Seeking Alpha • Jun 09
Concentrix: Too Cheap To Sell, Too Weak To Buy
Summary Concentrix trades at a low 2.4x forward non-GAAP earnings and offers a >5% dividend yield but faces significant operational and balance sheet challenges. Revenue growth is weak and uneven across verticals, with technology and healthcare declining, while margin recovery is delayed to the second half of 2026. AI-related wins and bookings are promising but have yet to materially improve consolidated results; management's guidance relies on future scaling and margin normalization. I rate CNXC a Hold with a negative bias, citing high leverage, unproven margin recovery, and reliance on adjusted metrics for the investment case. Read the full article on Seeking Alpha
Mise à jour du récit • Jun 07
CNXC: Margin Expansion And Buybacks Will Support Repriced Upside Potential
Analysts have reduced their price targets on Concentrix by $12 to $25, citing updated views on the company’s outlook. They maintained their fair value estimates and kept key model inputs such as discount rate, revenue growth, profit margin, and future P/E broadly unchanged.Mise à jour du récit • May 13
CNXC: Margin Resilience And Buybacks Will Support Repriced Upside Potential
Concentrix's analyst price target has been revised lower by a combined $24 to $25 across several firms, with analysts citing updated views on valuation and business outlook to support the adjustment. Analyst Commentary Across the latest research updates, analysts reduced their price targets for Concentrix by amounts ranging from $12 to $25, pointing to reassessments of valuation and the business outlook.Mise à jour du récit • Apr 25
CNXC: Margin Resilience And Buybacks Will Support Future Upside Potential
Analysts have trimmed their Concentrix price targets by $12 to $25, citing more conservative assumptions around future P/E multiples, while keeping fair value, discount rate, and margin expectations broadly unchanged. Analyst Commentary Bullish Takeaways Bullish analysts appear to see the P/E reset as a way to align expectations more closely with current sentiment, which can reduce the risk of overpaying for near term execution.Mise à jour du récit • Apr 10
CNXC: Higher Margin Outlook And Buybacks Will Support Future Upside Potential
Narrative Update The updated analyst price target for Concentrix moves from approximately $48.60 to about $41.25. This reflects recent cuts from several firms as analysts point to more measured revenue growth assumptions, offset by slightly higher projected profit margins and a lower future P/E multiple.Mise à jour du récit • Mar 27
CNXC: Higher Margin Outlook And Buybacks Will Support Future Undervalued Entry
The analyst price target for Concentrix has shifted from $62.20 to $48.60. Analysts attribute this change to updated assumptions around slower revenue growth, a higher profit margin profile, and a lower future P/E multiple following recent target cuts from Barrington, Baird, and Canaccord.Mise à jour du récit • Mar 12
CNXC: AI Rollout And Buybacks Will Support Future Undervalued Entry
Analysts have trimmed their price target on Concentrix by $4, reflecting updated views captured in recent research while keeping key fair value and growth assumptions essentially unchanged. Analyst Commentary Recent research around the $4 reduction in the price target highlights a mix of confidence in Concentrix’s core thesis and a more cautious stance on execution and risk.Mise à jour du récit • Feb 26
CNXC: Higher Discount Rate Assumptions Will Support Future Undervalued Entry
Analysts have trimmed their price target on Concentrix by $4, reflecting updated assumptions around discount rates and valuation multiples, while keeping fair value estimates for the business broadly unchanged. Analyst Commentary Analysts describe the $4 price target cut as a fine tuning of their models rather than a reset of their overall view on Concentrix, with fair value estimates broadly intact.Article d’analyse • Feb 16
Benign Growth For Concentrix Corporation (NASDAQ:CNXC) Underpins Stock's 30% Plummet
Concentrix Corporation ( NASDAQ:CNXC ) shareholders won't be pleased to see that the share price has had a very rough...Mise à jour du récit • Feb 12
CNXC: Updated Discount Rate Assumptions Will Support Future Undervalued Entry
Analysts have lowered their price target on Concentrix by $4, citing updated assumptions around discount rates and profitability, while keeping fair value estimates broadly stable. Analyst Commentary Analysts describe the recent US$4 reduction in the price target as a fine tuning of their view, reflecting updated discount rate assumptions and a more cautious stance on profitability, rather than a fundamental reset of Concentrix's underlying worth.Mise à jour du récit • Jan 29
CNXC: Updated Discount Rate And P/E Assumptions Will Support Future Undervalued Entry
Narrative Update on Concentrix Analysts have trimmed their price target on Concentrix by $4, citing updated assumptions around discount rates and future P/E expectations, while keeping their fair value estimate unchanged at $62.20. Analyst Commentary Recent research around Concentrix reflects a mixed tone, with the $4 trim to the price target tied mainly to updated discount rate inputs and revised P/E assumptions rather than a reset of the underlying fair value, which remains at $62.20.Mise à jour du récit • Jan 15
CNXC: Higher Discount Rate Reset Will Support Future Undervalued Entry Thesis
Analysts have trimmed their price target on Concentrix by about $2.63, citing updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E following recent research that included a $4 reduction highlighted at Baird. Analyst Commentary Analysts framing the new price target are trying to line up their fair value work with updated assumptions on discount rates, revenue growth, margins and the future P/E they think the market is willing to pay for Concentrix.Article d’analyse • Nov 08
Concentrix Corporation (NASDAQ:CNXC) Not Doing Enough For Some Investors As Its Shares Slump 28%
The Concentrix Corporation ( NASDAQ:CNXC ) share price has fared very poorly over the last month, falling by a...Article d’analyse • Sep 29
Concentrix's (NASDAQ:CNXC) Upcoming Dividend Will Be Larger Than Last Year's
The board of Concentrix Corporation ( NASDAQ:CNXC ) has announced that it will be paying its dividend of $0.36 on the...Mise à jour du récit • Sep 27
AI Integration And Webhelp Synergies Will Transform Business
Concentrix's consensus price target was modestly reduced to $64.83 as analysts factor in compressed valuation multiples from AI-related investor uncertainty and secular headwinds—rather than fundamental weakness—while maintaining confidence in growth reacceleration and strong business fundamentals. Analyst Commentary Compressed valuation multiples attributed to investor uncertainty over the impact of artificial intelligence on labor-intensive business models and broader secular headwinds, not due to fundamental company weakness.Article d’analyse • Apr 03
Concentrix Corporation's (NASDAQ:CNXC) Shares Leap 26% Yet They're Still Not Telling The Full Story
The Concentrix Corporation ( NASDAQ:CNXC ) share price has done very well over the last month, posting an excellent...Article d’analyse • Jan 29
The Market Lifts Concentrix Corporation (NASDAQ:CNXC) Shares 25% But It Can Do More
Concentrix Corporation ( NASDAQ:CNXC ) shareholders have had their patience rewarded with a 25% share price jump in the...Seeking Alpha • Jan 17
Concentrix: Better Than Expected Results, GenAI, And Cheap
Summary Concentrix Corporation delivered better-than-expected EPS and revenue, driven by significant investments in its GenAI product suite and a booming AI customer experience market. The AI in customer experience market is projected to grow at a 22% CAGR, potentially boosting CNXC's future revenue and free cash flow growth. Despite risks from high debt levels and potential global tariffs, CNXC's substantial headcount growth and consistent net income make it appear undervalued. My financial model suggests CNXC is significantly undervalued, with an equity valuation of $6.5 billion and a target price of $102 per share. Read the full article on Seeking AlphaSeeking Alpha • Dec 21
AI: Will Freshworks Leave Room For Concentrix?
Summary A.I. is revolutionising Customer Relationship Management (CRM), with Salesforce leading the market, leveraging Big Data to enhance customer interactions and sales conversions. Generative A.I. significantly boosts Customer Experience (CX) performance, with early adopters seeing a 25% increase in CX satisfaction, and the global CX market projected to grow to $33bn by 2030. Concentrix, with a $2.86bn market cap, offers comprehensive CX services including call centres. Freshworks is a SAAS only CX provider. Both companies have seen 70% plus share price declines, but one is still priced for growth, the other for business declines. Is this justified? Read the full article on Seeking AlphaSeeking Alpha • Nov 01
Concentrix: Significant Business Growth Driven By AI, And Cheap Valuation
Summary Concentrix's diversified client base, strong cash flow, and expanding AI-driven services make it a compelling buy at the current stock price. The company’s global presence and technological innovations in data analytics and AI are expected to drive future revenue and profitability growth. Concentrix's efficient debt management and significant undervaluation compared to peers suggest substantial upside potential. Despite potential risks from technological failures and client concentration, the company looks like a buy. Read the full article on Seeking AlphaArticle d’analyse • Oct 22
Positive Sentiment Still Eludes Concentrix Corporation (NASDAQ:CNXC) Following 26% Share Price Slump
The Concentrix Corporation ( NASDAQ:CNXC ) share price has fared very poorly over the last month, falling by a...
Nouveau récit • Sep 26
Generative AI And Decisive Shifts Poise Company For Future Profitability Surge
Concentrix's investment in generative AI and focus on transformational deals are poised to enhance productivity, future revenue, and margins through differentiated services.Seeking Alpha • Sep 19
Concentrix: Hardly Growing Post-Merger (Rating Downgrade)
Summary Concentrix's Q3 report is due next week; past performance shows no growth and decreased efficiency, leading to a 30% stock decline. Revenue growth mainly from WebHelp merger; organic growth flat, with margins impacted by increased R&D spending, affecting ROA and ROE negatively. The company’s financial health is concerning with high debt and low interest coverage ratio, necessitating a conservative valuation approach. Downgrading to a hold rating; awaiting proof of improved growth and profitability from AI and merger before recommending a buy again. Read the full article on Seeking AlphaArticle d’analyse • Aug 21
Concentrix Corporation (NASDAQ:CNXC) Might Not Be As Mispriced As It Looks
With a median price-to-earnings (or "P/E") ratio of close to 18x in the United States, you could be forgiven for...Seeking Alpha • Jun 04
Concentrix: Worth A Look
Summary Concentrix Corporation's stock has declined by 40% since becoming an independent public entity. The merger with Webhelp will boost Concentrix's competitive profile and increase its exposure to the EMEA region. Despite its strong forward earnings growth profile (triple-digit growth in FY24, followed by double-digit growth through FY26), CNXC can be picked up at a forward P/E of less than 5x. Despite an adverse Q1, mainly due to one-off and seasonal issues, FCF generation will pick up meaningfully over the next 3 quarters and help the company deleverage to 2.5x net leverage. The charts are showing signs of bottoming out, and could receive additional support from an expected ramp-up in the buyback run rate. Read the full article on Seeking AlphaAnalyse de la situation financière
Passif à court terme: Les actifs à court terme de CNXC ( $3.0B ) dépassent ses passifs à court terme ( $2.6B ).
Passif à long terme: Les actifs à court terme de CNXC ( $3.0B ) ne couvrent pas ses passifs à long terme ( $5.3B ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de CNXC ( 162.4% ) est considéré comme élevé.
Réduire la dette: Le ratio d'endettement de CNXC est passé de 46.6% à 170.4% au cours des 5 dernières années.
Couverture de la dette: La dette de CNXC n'est pas bien couverte par le flux de trésorerie opérationnel ( 15.2% ).
Couverture des intérêts: Les paiements d'intérêts de CNXC sur sa dette ne sont pas bien couverts par l'EBIT ( 1.6 x couverture).
Bilan
Découvrir des entreprises saines
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/06/10 10:51 |
| Cours de l'action en fin de journée | 2026/06/10 00:00 |
| Les revenus | 2026/02/28 |
| Revenus annuels | 2025/11/30 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Concentrix Corporation est couverte par 5 analystes. 3 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| David Koning | Baird |
| Vincent Colicchio | Barrington Research Associates, Inc. |
| Ruplu Bhattacharya | BofA Global Research |